Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma. [electronic resource]
Producer: 20151102Description: 929-35 p. digitalISSN:- 1873-7560
- Adult
- Aged
- Aged, 80 and over
- Antigens, Neoplasm -- analysis
- Biomarkers, Tumor -- analysis
- Biopsy
- Carcinoma, Renal Cell -- enzymology
- DNA Topoisomerases, Type II -- analysis
- DNA-Binding Proteins -- analysis
- Female
- Florida
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Kidney Neoplasms -- enzymology
- Male
- Middle Aged
- Minnesota
- Multivariate Analysis
- Necrosis
- Neoplasm Grading
- Neoplasm Staging
- Nephrectomy -- adverse effects
- Observer Variation
- Predictive Value of Tests
- Proportional Hazards Models
- Registries
- Reproducibility of Results
- Risk Assessment
- Risk Factors
- Tertiary Care Centers
- Time Factors
- Treatment Outcome
- Tumor Burden
- Up-Regulation
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, N.I.H., Extramural; Validation Study
There are no comments on this title.
Log in to your account to post a comment.